SHEDding light on the role of Pragmin pseudo-kinases in cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The human kinome includes over 50 pseudo-kinases with poorly understood functions, often disregarded in cancer drug discovery.
• Despite lacking catalytic activity, pseudo-kinases like the Pragmin family are increasingly recognized for their significant roles in human cancer.
• The oncogenic mechanisms of pseudo-kinases remain largely unexplored.

Discussion:

• Recent structural studies on Pragmin, SGK223, and SGK269/PEAK1 revealed a split helical dimerization (SHED)-based mechanism.
• C19orf35 has been identified as a novel member of the Pragmin pseudo-kinase family through sequence-structure analysis.
• A unified model is proposed for how Pragmin pseudo-kinases regulate oncogenic signaling pathways.

Key Insights:

• Pseudo-kinases, particularly the Pragmin family, are critical drivers of tumor formation.
• The SHED mechanism explains the functional activity of these pseudo-kinases.
• Understanding these mechanisms opens avenues for targeted cancer therapies.

Outlook:

• Further research into the SHED mechanism and its role in oncogenic signaling is warranted.
• Development of therapeutic strategies targeting Pragmin pseudo-kinases could offer new cancer treatment options.
• Investigating C19orf35's role in cancer will expand our understanding of the Pragmin family.